| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 吉林省集安益盛药业股份有限公司是一家从事中成药的研发、生产与销售的企业.其主要产品包括生脉注射液、振源胶囊、心悦胶囊、清开灵注射液、桂附地黄胶囊等,产品的治疗范围以心脑血管疾病为主.公司可生产11个剂型,拥有116个品种、129个药品生产批准文号.其中51个品种被列入国家医保目录,3个品种被列入《国家基本药物目录》,拥有国家中药保护品种4个,独家品种6个。 | ||||||||||||||||||||||||
| Main Business | 中成药研发、生产、销售。 | ||||||||||||||||||||||||
| Legal Representative | 张益胜 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 李铁军 | ||||||||||||||||||||||||
| Solicitors | 北京市国枫律师事务所 | ||||||||||||||||||||||||
| Auditors | 利安达会计师事务所有限责任公司 | ||||||||||||||||||||||||
| Tel No | 0435-6236009;0435-6236050 | ||||||||||||||||||||||||
| Fax No | 0435-6236009 | ||||||||||||||||||||||||
| Website | www.yisheng-pharm.com | ||||||||||||||||||||||||
| yisheng@yisheng-pharm.com；comjunlitie@sina.comjunlitie@sina.comjunlitie@sina.comjunlitie@sina.comjun | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 18/03/2011 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 0.286 | ||||||||||||||||||||||||
| DPS(RMB)* | ¥ 0.150 | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 6.748 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 1.692B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Chiyu Banking Corporation Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |